Mutant p53 proteins behave in a dominant, negative fashion in vivoHACHIYA, M; CHUMAKOV, A; MILLER, C. W et al.Anticancer research. 1994, Vol 14, Num 5A, pp 1853-1859, issn 0250-7005Article

Integrin β3 down-regulates invasive features of ovarian cancer cells in SKOV3 cell subclonesJIE CHEN; JIE ZHANG; YAORAN ZHAO et al.Journal of cancer research and clinical oncology. 2009, Vol 135, Num 7, pp 909-917, issn 0171-5216, 9 p.Article

Cycloheximide-induced modulation of TNF-mediated cytotoxicity in sensitive and resistant ovarian tumor cellsNIO, Y; ZIGHELBOIM, J; BEREK, J et al.Cancer chemotherapy and pharmacology. 1990, Vol 26, Num 1, pp 1-8, issn 0344-5704, 8 p.Article

Complement resistance of human carcinoma cells depends on membrane regulatory proteins, protein kinases and sialic acidDONIN, N; JURIANZ, K; ZIPOREN, L et al.Clinical and experimental immunology (Print). 2003, Vol 131, Num 2, pp 254-263, issn 0009-9104, 10 p.Article

Release of intracellular calcium and stimulation of cell growth by ATP and histamine in human ovarian cancer cells (SKOV-3)BATRA, S; FADEEL, I.Cancer letters. 1994, Vol 77, Num 1, pp 57-63, issn 0304-3835Article

Differential processing of antitumour-active and antitumour-inactive trans platinum compounds by SKOV-3 ovarian cancer cellsBOCCARELLI, Angelina; GIORDANO, Domenico; NATILE, Giovanni et al.Biochemical pharmacology. 2006, Vol 72, Num 3, pp 280-292, issn 0006-2952, 13 p.Article

Intracellular metabolism of the orally active platinum drug JM216 : influence of glutathione levelsRAYNAUD, F. I; ODELL, D. E; KELLAND, L. R et al.British journal of cancer. 1996, Vol 74, Num 3, pp 380-386, issn 0007-0920Article

Response of four human ovarian carcinoma cell lines to all-trans retinoic acid : relationship with induction of differentiation and retinoic acid receptor expressionCLIARO, M. J; MARMOUGET, C; GUICHARD, S et al.International journal of cancer. 1994, Vol 56, Num 5, pp 743-748, issn 0020-7136Article

Anti-EGFR monoclonal antibodies which act as EGF, TGFα, HB-EGF and BTC antagonists block the binding of epiregulin to EGFR-expressing tumoursMODJTAHEDI, H; KOMURASARI, T; TOYODA, H et al.International journal of cancer. 1998, Vol 75, Num 2, pp 310-316, issn 0020-7136Article

SNAI1 overexpression induces stemness and promotes ovarian cancer cell invasion and metastasisLU, Zhen-Yu; RONG DONG; DONG LI et al.Oncology reports. 2012, Vol 27, Num 5, pp 1587-1591, issn 1021-335X, 5 p.Article

Tubeimoside-1 induces G2/M phase arrest and apoptosis in SKOV-3 cells through increase of intracellular Ca²⁺ and caspase-dependent signaling pathwaysCHEN, Wen-Juan; CHAO YU; ZHU YANG et al.International journal of oncology. 2012, Vol 40, Num 2, pp 535-543, issn 1019-6439, 9 p.Article

Murine monoclonal anti-idiotypic antibody as a surrogate antigen for human Her-2/neuBARAL, Rathindranath; SHERRAT, Amanda; DAS, Ruma et al.International journal of cancer. 2001, Vol 92, Num 1, pp 88-95, issn 0020-7136Article

Constitutive production of interleukin 6 by ovarian cancer cell lines and by primary ovarian tumor culturesWATSON, J. M; SENSINTAFFAR, J. L; BEREK, J. S et al.Cancer research (Baltimore). 1990, Vol 50, Num 21, pp 6959-6965, issn 0008-5472, 7 p.Article

P-glycoprotein expression in ovarian cancer cell line following treatment with cisplatinXIAOWEI YANG; PAGE, M.Oncology research. 1995, Vol 7, Num 12, pp 619-624, issn 0965-0407Article

Regio- and Stereospecific Synthesis of Mono-β-D-Glucuronic Acid Derivatives of Combretastatin A-1TANPURE, Rajendra P; STRECKER, Tracy E; CHAPLIN, David J et al.Journal of natural products (Print). 2010, Vol 73, Num 6, pp 1093-1101, issn 0163-3864, 9 p.Article

Fatty acid synthase inhibition activates AMP-activated protein kinase in SKOV3 human ovarian cancer cellsWEIBO ZHOU; WAN FANG HAN; RONNETT, Gabriele V et al.Cancer research (Baltimore). 2007, Vol 67, Num 7, pp 2964-2971, issn 0008-5472, 8 p.Article

ErbB receptor expression and growth response to heregulin ss1 in five ovarian carcinoma linesPEGUES, J. C; KANNAN, B; STROMBERG, K et al.International journal of oncology. 1999, Vol 14, Num 6, pp 1169-1176, issn 1019-6439Article

An in vivo model to compare human leukocyte infiltration in carcinoma xenografts producing different chemokinesMELANI, C; PUPA, S. M; STOPPACCIARO, A et al.International journal of cancer. 1995, Vol 62, Num 5, pp 572-578, issn 0020-7136Article

SKOV3 ovarian carcinoma cells have functional estrogen receptor but are growth-resistant to estrogen and antiestrogensWENHUA HUA; CHRISTIANSON, T; ROUGEOT, C et al.Journal of steroid biochemistry and molecular biology. 1995, Vol 55, Num 3-4, pp 279-289, issn 0960-0760Article

Ligand-like effects induced by anti-c-erbB-2 antibodies do not correlate with an are not required for growth inhibition of human carcinoma cellsSHAWVER, L. K; MANN, E; ELLIGER, S. S et al.Cancer research (Baltimore). 1994, Vol 54, Num 5, pp 1367-1373, issn 0008-5472Article

Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44HCANNISTRA, S. A; KANSAS, G. S; NILOFF, J et al.Cancer research (Baltimore). 1993, Vol 53, Num 16, pp 3830-3838, issn 0008-5472Article

Total synthesis of topsentolide B₂FERNANDES, Rodney A; KATTANGURU, Pullaiah.Tetrahedron letters. 2011, Vol 52, Num 15, issn 0040-4039, 1728, 1788-1790 [4 p.]Article

A 2-Substituted Prodiginine, 2-(p-Hydroxybenzyl)prodigiosin, from Pseudoalteromonas rubraFEHER, Domonkos; BARLOW, Russell S; LORENZO, Patricia S et al.Journal of natural products (Print). 2008, Vol 71, Num 11, pp 1970-1972, issn 0163-3864, 3 p.Article

Overexpression of LASP-I mediates migration and proliferation of human ovarian cancer cells and influences zyxin localisationGRUNEWALD, T. G. P; KAMMERER, U; WINKLER, C et al.British journal of cancer. 2007, Vol 96, Num 2, pp 296-305, issn 0007-0920, 10 p.Article

Aurintricarboxylic acid decreases proliferative potential of SKOV3 and MCF7 human carcinoma cellsFRAIFELD, Vadim; SEIDMAN, Rachel; SAGI, Orli et al.Anticancer research. 2001, Vol 21, Num 3B, pp 1975-1978, issn 0250-7005Article